Evidence map›Paper›PMID 41249229›Full record

ArticleScientific reports2025

Advantage of grading classification using volumetric artificial intelligence for periventricular hyperintensity and deep subcortical white matter hyperintensity.

Masashi Kuwabara, Fusao Ikawa, Shinji Nakazawa, Saori Koshino, Daizo Ishii, Hiroshi Kondo, Takeshi Hara, Shingo Matsuda, Yuyo Maeda, Shiyuki Maeyama and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Masashi KuwabaraDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8551, Japan.
Fusao IkawaDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8551, Japan. fikawa-nsu@umin.ac.jp.ORCID http://orcid.org/0000-0003-4205-1490
Shinji NakazawaLPIXEL Inc, 1-6-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Saori KoshinoDepartment of Radiology, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Daizo IshiiDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8551, Japan.
Hiroshi KondoDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8551, Japan.
Takeshi HaraDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8551, Japan.
Shingo MatsudaDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8551, Japan.
Yuyo MaedaDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8551, Japan.
Shiyuki MaeyamaLPIXEL Inc, 1-6-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Yoshinobu SeoDepartment of Neurosurgery, Nakamura Memorial Hospital, South-1, West-14, Chuo-ku, Sapporo, 060-8570, Hokkaido, Japan.
Jinichi SasanumaDepartment of Neurosurgery, Shin-yurigaoka General Hospital, 255, Furusawa-Miyako, Kawasaki Asao-ku, Kanagawa, 215-0026, Japan.
Kimito KondoDepartment of Neurology, Hokuto Hospital, 7-5 Kisen, Inada-cho, Obihiro, 080- 0833, Hokkaido, Japan.
Nobutaka HorieDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8551, Japan.

Funding

The Japan Society for the Promotion of Science under the Grant-in-Aid for Scientific Research (C)23K08521
6 · The paper itself

Abstract

We developed and validated an artificial intelligence (AI) algorithm for the automated grading of periventricular hyperintensity (PVH) and deep subcortical white matter hyperintensity (DWMH) using magnetic resonance imaging. Overall, 246 patients were evaluated, with 137 and 109 allocated to the training and testing groups, respectively. AI-predicted grading according to the Fazekas scale was compared with expert assessments using accuracy, F1-score, and mean absolute error. Inter-rater agreement was evaluated using Fleiss' kappa to assess consistency among human raters and Cohen's kappa to measure agreement between the AI and individual human raters. The AI demonstrated superior multi-class accuracy in PVH classification compared with the human expert, achieving an accuracy of 0.798 versus 0.743. In DWMH classification, the AI outperformed the expert specifically in distinguishing Fazekas 0/1/2 from the 3 classification, achieving an accuracy of 0.954 compared with the expert's 0.927. Inter-rater agreement analysis showed that for PVH and DWMH, the AI achieved "good agreement" with human raters. For PVH, the AI's agreement exceeded the human inter-rater agreement. The developed AI also exhibited lower variability in volume ratio distribution within the same grade compared with human raters. The developed AI algorithm effectively distinguished between PVH and DWMH, achieving accuracy comparable to human performance.

Indexed as

Artificial IntelligenceMagnetic Resonance ImagingWhite MatterAdultAgedAlgorithmsFemaleHumansMaleMiddle AgedArtificial intelligenceDeep and subcortical white matter hyperintensityGradingMagnetic resonance imagingPeriventricular hyperintensity

Identifiers

PMID41249229
PMCPMC12624063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.